Position in ACIU
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$21,010
-$6,373 QoQ
Shares Held
7,640
-12.4% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACIU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. ACIU ranks #283 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
24,150,499 | $3,949,089,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,311,806 | $3,331,473,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,033,156 | $3,140,585,469 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,323,752 | $2,092,339,815 | |
| 5 | NUVL |
Nuvalent, Inc.
|
3,088,349 | $316,401,351 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,204,353 | $227,682,931 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
2,363,567 | $177,480,242 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
2,869,728 | $151,292,056 |
All Filings in ACIU
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,010 | 7,640 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $27,383 | 8,721 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $20,978 | 7,259 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $12,403 | 6,110 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $13,290 | 7,107 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $22,744 | 8,424 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $40,430 | 10,696 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $45,294 | 11,352 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $65,460 | 22,115 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $21,390 | 4,278 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $3,420 | 1,200 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $8,073 | 2,732 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,392 | 2,732 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $5,573 | 2,732 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $16,656 | 5,271 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,678 | 3,512 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $37,720 | 9,430 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $34,808 | 7,032 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $108,238 | 16,131 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $27,287 | 3,441 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $251 | 33 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $170 | 33 | Shares | Defined | 2021-02-19 | |
| No filing history on record for this holder in this stock. | ||||||